BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33478746)

  • 1. Alloimmune Myositis as Paraneoplastic Complication of an Oral Squamous Cell Carcinoma After Severe Chronic Graft vs Host Disease or a Manifestation of Chronic Graft vs Host Disease? A Case Report and Literature Discussion.
    Woelfinger P; Hauptrock B; Kriege O; Wagner W; Heider J; Schwarting A; Birklein F; Theobald M; Wagner-Drouet EM
    Transplant Proc; 2021 May; 53(4):1365-1368. PubMed ID: 33478746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chronic graft-versus-host-disease involving the oral mucosa: clinical presentation and treatment].
    Elad S; Levitt M; M Y S
    Refuat Hapeh Vehashinayim (1993); 2008 Nov; 25(4):19-27, 72. PubMed ID: 19263864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case with myositis as a manifestation of chronic graft-versus-host-disease (GVHD) with severe muscle swelling developed after aggressive muscular exercise].
    Kano S; Shimizu J; Mikata T; Shinoe T; Ota H; Komeno Y; Ogawa S; Hirai H; Kanazawa I
    Rinsho Shinkeigaku; 2003 Mar; 43(3):93-7. PubMed ID: 12820556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis.
    Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D
    Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia.
    Yang J; Cai Y; Jiang J; Wan L; Bai H; Zhu J; Li S; Wang C; Song X
    Ann Hematol; 2018 Mar; 97(3):497-507. PubMed ID: 29250743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report and literature review of chronic graft-versus-host disease manifesting as polymyositis.
    Michelis FV; Bril V; Lipton JH
    Int J Hematol; 2015 Jul; 102(1):144-6. PubMed ID: 25732066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of meningeal graft-versus-host disease in a haematopoietic stem cell transplant recipient.
    Pechey V; Parratt J; Vo L; Stevenson W
    Int J Hematol; 2015 Feb; 101(2):203-6. PubMed ID: 25416235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor Lymphocyte Infusions for Chronic Myeloid Leukemia Relapsing after Allogeneic Stem Cell Transplantation: May We Predict Graft-versus-Leukemia Without Graft-versus-Host Disease?
    Radujkovic A; Guglielmi C; Bergantini S; Iacobelli S; van Biezen A; Milojkovic D; Gratwohl A; Schattenberg AV; Verdonck LF; Niederwieser DW; de Witte T; Kröger N; Olavarria E;
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1230-6. PubMed ID: 25797175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral chronic graft-versus-host disease: current pathogenesis, therapy, and research.
    Mays JW; Fassil H; Edwards DA; Pavletic SZ; Bassim CW
    Oral Dis; 2013 May; 19(4):327-46. PubMed ID: 23107104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study.
    Bonifazi F; Solano C; Wolschke C; Sessa M; Patriarca F; Zallio F; Nagler A; Selleri C; Risitano AM; Messina G; Bethge W; Herrera P; Sureda A; Carella AM; Cimminiello M; Guidi S; Finke J; Sorasio R; Ferra C; Sierra J; Russo D; Benedetti E; Milone G; Benedetti F; Heinzelmann M; Pastore D; Jurado M; Terruzzi E; Narni F; Völp A; Ayuk F; Ruutu T; Kröger N
    Lancet Haematol; 2019 Feb; 6(2):e89-e99. PubMed ID: 30709437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease of the kidney in patients with allogenic hematopoietic stem cell transplant.
    Fraile P; Vazquez L; Caballero D; Garcia-Cosmes P; López L; San Miguel J; Tabernero JM
    Eur J Haematol; 2013 Aug; 91(2):129-34. PubMed ID: 23710658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of inflammatory myopathy in graft vs host disease - A potential role for ibrutinib.
    Wilkinson M; Yeung D; Limaye V
    Neuromuscul Disord; 2021 Sep; 31(9):865-869. PubMed ID: 34334272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic graft versus host disease of oral mucosa: review of available therapies.
    Imanguli MM; Pavletic SZ; Guadagnini JP; Brahim JS; Atkinson JC
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Feb; 101(2):175-83. PubMed ID: 16448918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of upper gingiva carcinoma with chronic graft-versus-host disease after allogenic bone marrow transplantation.
    Tsushima F; Sakurai J; Harada H
    Aust Dent J; 2015 Sep; 60(3):404-7. PubMed ID: 26211810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapsing polymyositis in chronic graft versus host disease.
    Sharaf N; Prayson RA
    J Clin Neurosci; 2014 Nov; 21(11):1964-5. PubMed ID: 24980629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary Skin Cancer in a Case with Long-term Voriconazole after Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
    Kawano N; Nakamura S; Mochida K; Yoshida S; Kuriyama T; Nakaike T; Shimokawa T; Tochigi T; Yamashita K; Mashiba K; Kikuchi I; Takarabe A; Moriguchi S; Mori Y; Takenaka K; Shimoda K; Ochiai H; Amano M
    Intern Med; 2022 Sep; 61(18):2771-2774. PubMed ID: 35022348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of chronic GVHD after oral treatment with Clostridium butyricum (Miya BM).
    Kaya H; Okumura H; Ishizawa S
    Anaerobe; 2022 Aug; 76():102612. PubMed ID: 35840013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of dry eye in two patients with chronic graft-versus-host disease with systemic administration of FK506 and corticosteroids.
    Ogawa Y; Okamoto S; Kuwana M; Mori T; Watanabe R; Nakajima T; Yamada M; Mashima Y; Tsubota K; Oguchi Y
    Cornea; 2001 May; 20(4):430-4. PubMed ID: 11333336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral involvement of chronic graft-versus-host disease in hematopoietic stem cell transplant recipients.
    Noce CW; Gomes A; Copello A; Barbosa RD; Sant'anna S; Moreira MC; Correa ME; Maiolino A; Torres SR
    Gen Dent; 2011; 59(6):458-62; quiz 463-4. PubMed ID: 22313917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.